NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026
FORT MYERS, Fla.--(BUSINESS WIRE)--July 07, 2026--NeoGenomics, Inc. NASDAQ:NEO, a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its second quarter 2026 financial results after the close of U.S. financial markets on Tuesday, Jul…